- $617.16m
- $579.21m
- $287.92m
- 78
- 28
- 80
- 65
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 249 | 347 | 419 | 404 | 288 |
Cost of Revenue | |||||
Gross Profit | 233 | 326 | 395 | 380 | 265 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 257 | 359 | 440 | 429 | 340 |
Operating Profit | -8.05 | -11.7 | -21.9 | -24.8 | -52 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -7.12 | -11.2 | -21.9 | -24.4 | -50.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -7.12 | -11.2 | -19.4 | -24.4 | -51.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -7.12 | -11.2 | -19.4 | -24.4 | -51.3 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -7.12 | -11.2 | -19.4 | -24.4 | -51.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.229 | -0.327 | -0.644 | -0.903 | -1.08 |